636 related articles for article (PubMed ID: 31928404)
1. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
Allison KH; Hammond MEH; Dowsett M; McKernin SE; Carey LA; Fitzgibbons PL; Hayes DF; Lakhani SR; Chavez-MacGregor M; Perlmutter J; Perou CM; Regan MM; Rimm DL; Symmans WF; Torlakovic EE; Varella L; Viale G; Weisberg TF; McShane LM; Wolff AC
J Clin Oncol; 2020 Apr; 38(12):1346-1366. PubMed ID: 31928404
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.
Allison KH; Hammond MEH; Dowsett M; McKernin SE; Carey LA; Fitzgibbons PL; Hayes DF; Lakhani SR; Chavez-MacGregor M; Perlmutter J; Perou CM; Regan MM; Rimm DL; Symmans WF; Torlakovic EE; Varella L; Viale G; Weisberg TF; McShane LM; Wolff AC
Arch Pathol Lab Med; 2020 May; 144(5):545-563. PubMed ID: 31928354
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).
Hammond ME; Hayes DF; Dowsett M; Allred DC; Hagerty KL; Badve S; Fitzgibbons PL; Francis G; Goldstein NS; Hayes M; Hicks DG; Lester S; Love R; Mangu PB; McShane L; Miller K; Osborne CK; Paik S; Perlmutter J; Rhodes A; Sasano H; Schwartz JN; Sweep FC; Taube S; Torlakovic EE; Valenstein P; Viale G; Visscher D; Wheeler T; Williams RB; Wittliff JL; Wolff AC; ;
Arch Pathol Lab Med; 2010 Jul; 134(7):e48-72. PubMed ID: 20586616
[TBL] [Abstract][Full Text] [Related]
4. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
Hammond ME; Hayes DF; Dowsett M; Allred DC; Hagerty KL; Badve S; Fitzgibbons PL; Francis G; Goldstein NS; Hayes M; Hicks DG; Lester S; Love R; Mangu PB; McShane L; Miller K; Osborne CK; Paik S; Perlmutter J; Rhodes A; Sasano H; Schwartz JN; Sweep FC; Taube S; Torlakovic EE; Valenstein P; Viale G; Visscher D; Wheeler T; Williams RB; Wittliff JL; Wolff AC
Arch Pathol Lab Med; 2010 Jun; 134(6):907-22. PubMed ID: 20524868
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
Hammond ME; Hayes DF; Dowsett M; Allred DC; Hagerty KL; Badve S; Fitzgibbons PL; Francis G; Goldstein NS; Hayes M; Hicks DG; Lester S; Love R; Mangu PB; McShane L; Miller K; Osborne CK; Paik S; Perlmutter J; Rhodes A; Sasano H; Schwartz JN; Sweep FC; Taube S; Torlakovic EE; Valenstein P; Viale G; Visscher D; Wheeler T; Williams RB; Wittliff JL; Wolff AC
J Clin Oncol; 2010 Jun; 28(16):2784-95. PubMed ID: 20404251
[TBL] [Abstract][Full Text] [Related]
6. NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.
Allred DC; Carlson RW; Berry DA; Burstein HJ; Edge SB; Goldstein LJ; Gown A; Hammond ME; Iglehart JD; Moench S; Pierce LJ; Ravdin P; Schnitt SJ; Wolff AC
J Natl Compr Canc Netw; 2009 Sep; 7 Suppl 6():S1-S21; quiz S22-3. PubMed ID: 19755043
[TBL] [Abstract][Full Text] [Related]
7. What to Expect From the New ASCO/CAP Guideline Recommendations for Hormone Receptor Testing in Breast Cancer: A National Reference Laboratory Experience.
Mahlow J; Goold EA; Jedrzkiewicz J; Gulbahce HE
Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):245-250. PubMed ID: 33306617
[TBL] [Abstract][Full Text] [Related]
8. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.
Asogan AB; Hong GS; Arni Prabhakaran SK
Singapore Med J; 2017 Mar; 58(3):145-149. PubMed ID: 27029805
[TBL] [Abstract][Full Text] [Related]
9. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Wolff AC; Hammond MEH; Allison KH; Harvey BE; Mangu PB; Bartlett JMS; Bilous M; Ellis IO; Fitzgibbons P; Hanna W; Jenkins RB; Press MF; Spears PA; Vance GH; Viale G; McShane LM; Dowsett M
J Clin Oncol; 2018 Jul; 36(20):2105-2122. PubMed ID: 29846122
[TBL] [Abstract][Full Text] [Related]
10. Predictive markers in breast cancer: An update on ER and HER2 testing and reporting.
Calhoun BC; Collins LC
Semin Diagn Pathol; 2015 Sep; 32(5):362-9. PubMed ID: 25770732
[TBL] [Abstract][Full Text] [Related]
11. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Wolff AC; Hammond MEH; Allison KH; Harvey BE; Mangu PB; Bartlett JMS; Bilous M; Ellis IO; Fitzgibbons P; Hanna W; Jenkins RB; Press MF; Spears PA; Vance GH; Viale G; McShane LM; Dowsett M
Arch Pathol Lab Med; 2018 Nov; 142(11):1364-1382. PubMed ID: 29846104
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Estrogen and Progesterone Receptor Antibody Reagents Using Proficiency Testing Data.
Troxell ML; Long T; Hornick JL; Ambaye AB; Jensen KC
Arch Pathol Lab Med; 2017 Oct; 141(10):1402-1412. PubMed ID: 28714765
[TBL] [Abstract][Full Text] [Related]
13. Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations.
Henry NL; Somerfield MR; Abramson VG; Allison KH; Anders CK; Chingos DT; Hurria A; Openshaw TH; Krop IE
J Clin Oncol; 2016 Jul; 34(19):2303-11. PubMed ID: 27001586
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining.
Kuroda H; Muroi N; Hayashi M; Harada O; Hoshi K; Fukuma E; Abe A; Kubota K; Imai Y
Breast Cancer; 2019 Mar; 26(2):249-254. PubMed ID: 30066060
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
[TBL] [Abstract][Full Text] [Related]
16. Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.
Yu KD; Jiang YZ; Hao S; Shao ZM
BMC Med; 2015 Oct; 13():254. PubMed ID: 26437901
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Wolff AC; Hammond ME; Schwartz JN; Hagerty KL; Allred DC; Cote RJ; Dowsett M; Fitzgibbons PL; Hanna WM; Langer A; McShane LM; Paik S; Pegram MD; Perez EA; Press MF; Rhodes A; Sturgeon C; Taube SE; Tubbs R; Vance GH; van de Vijver M; Wheeler TM; Hayes DF; ;
J Clin Oncol; 2007 Jan; 25(1):118-45. PubMed ID: 17159189
[TBL] [Abstract][Full Text] [Related]
18. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Wolff AC; Hammond ME; Hicks DG; Dowsett M; McShane LM; Allison KH; Allred DC; Bartlett JM; Bilous M; Fitzgibbons P; Hanna W; Jenkins RB; Mangu PB; Paik S; Perez EA; Press MF; Spears PA; Vance GH; Viale G; Hayes DF; ;
J Clin Oncol; 2013 Nov; 31(31):3997-4013. PubMed ID: 24101045
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.
Fan Y; Ding X; Xu B; Ma F; Yuan P; Wang J; Zhang P; Li Q; Luo Y
Medicine (Baltimore); 2015 Nov; 94(46):e2066. PubMed ID: 26579819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
